Literature DB >> 6328310

Expression of a VHC kappa chimaeric protein in mouse myeloma cells.

J Sharon, M L Gefter, T Manser, S L Morrison, V T Oi, M Ptashne.   

Abstract

The heavy (H) and light (L) chains of antibodies consist of variable (V) and constant (C) regions. The V regions of the heavy and light chains form the antibody combining site. To determine whether a V region could be functional when joined to a polypeptide other than its own C region, we constructed a chimaeric gene encoding the V region of a mouse heavy chain and the C region of a mouse kappa light chain ( VHC kappa). The heavy-chain gene is derived from an A/J mouse hybridoma cell line 36-65 whose antibody product (gamma 1, kappa) is specific for the hapten azophenylarsonate. We report here that, when introduced into a mouse myeloma cell line, the chimaeric gene is expressed and a protein of the expected molecular weight is secreted into the medium. As light chains tend to dimerize we expected that the VHC kappa protein might associate with light chain from the cell line 36-65 to form an antibody-binding molecule. Affinity binding experiments and Ka determination indicate that this is the case. Dimers of this type offer a novel and interesting alternative to existing antibody-binding molecules.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328310     DOI: 10.1038/309364a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  11 in total

1.  Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting.

Authors:  H P Fell; S Yarnold; I Hellström; K E Hellström; K R Folger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Site-directed mutagenesis of an invariant amino acid residue at the variable-diversity segments junction of an antibody.

Authors:  J Sharon; M L Gefter; T Manser; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Secretion of a chimeric T-cell receptor-immunoglobulin protein.

Authors:  N R Gascoigne; C C Goodnow; K I Dudzik; V T Oi; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 4.  Expression of recombinant immunoglobulin genes to produce novel molecules with specific functions.

Authors:  C A Gritzmacher
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  Different ways to modify monoclonal antibodies.

Authors:  G Köhler; B Baumann; A Iglesias; J McCubrey; M J Potash; A Traunecker; D Zhu
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

6.  Isotope-detected 1H NMR studies of proteins: a general strategy for editing interproton nuclear Overhauser effects by heteronuclear decoupling, with application to phage lambda repressor.

Authors:  M A Weiss; A G Redfield; R H Griffey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Structural correlates of high antibody affinity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold.

Authors:  J Sharon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  cDNA of the immunoglobulin kappa chain of an Epstein-Barr virus-transformed human lymphoid cell line: partial sequence determination and bacterial expression.

Authors:  J W Morin; A Black; M Wu; S Beychok
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Antibody domain mutants demonstrate autonomy of the antigen binding site.

Authors:  T Simon; K Rajewsky
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Derivation and diversification of monoclonal antibodies.

Authors:  G Köhler
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.